At baseline, we observed a higher DNA-binding activity of p65, as reported previously [9], but not of p52 in MYD88-mutated compared to -unmutated CLL cells (Supplementary Fig. S10). The gene discussed is MYD88; the disease is B-cell chronic lymphocytic leukemia.